Quanterix Corp (QTRX)

$5.68 -0.04 (-0.70%)
Market Cap 265.79M
Revenue (ttm) 137.42M
Net Income (ttm) -38.53M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -28.04%
Debt to Equity Ratio 0.00
Volume 512,900
Avg Vol 557,068
Day's Range N/A - N/A
Shares Out 46.47M
Stochastic %K 14%
Beta 1.07
Analysts Hold
Price Target $6.00

Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Sim...

Industry: Medical Devices
Sector: Healthcare
Phone: 617 301 9400
Address:
Building 1, 900 Middlesex Turnpike, Billerica, United States
Farorm
Farorm Oct. 16 at 5:26 PM
$QTRX it’s time 🚀
0 · Reply
Will2ride1
Will2ride1 Oct. 9 at 6:52 PM
$QTRX when the CFO buys...you buy
0 · Reply
smartmoney43
smartmoney43 Oct. 8 at 10:04 PM
$QTRX looks interesting
0 · Reply
TAE63
TAE63 Oct. 5 at 6:23 PM
A steady mover to launch the week points to $QTRX .
0 · Reply
Will2ride1
Will2ride1 Oct. 3 at 2:04 PM
$QTRX 👁📈
0 · Reply
Will2ride1
Will2ride1 Oct. 2 at 8:03 PM
$QTRX ✅️
0 · Reply
sogenerous
sogenerous Oct. 1 at 2:34 PM
$QTRX sold half here +8%
1 · Reply
sogenerous
sogenerous Oct. 1 at 1:53 PM
$QTRX im 2 good to you guys
1 · Reply
ahab
ahab Sep. 29 at 3:03 PM
$QTRX Joining So generous on this one, nice setup PT$7
0 · Reply
sogenerous
sogenerous Sep. 29 at 2:13 PM
$QTRX I have rebought a starter in this name after a long time. Trading at negative valuation to cash and huge insider buys. hopefully I will get the bottom this time on this name like the last 2 times.
1 · Reply
Latest News on QTRX
Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit

Aug 21, 2025, 4:30 PM EDT - 2 months ago

Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit

Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference

Aug 11, 2025, 7:00 AM EDT - 2 months ago

Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference

Quanterix Corporation (QTRX) Q2 2025 Earnings Call Transcript

Aug 9, 2025, 2:27 AM EDT - 2 months ago

Quanterix Corporation (QTRX) Q2 2025 Earnings Call Transcript

Quanterix Releases Financial Results for the Second Quarter of 2025

Aug 7, 2025, 4:06 PM EDT - 2 months ago

Quanterix Releases Financial Results for the Second Quarter of 2025

Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025

Aug 4, 2025, 4:02 PM EDT - 3 months ago

Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025

Quanterix Announces Cooperation Agreement with Kent Lake Capital

Aug 4, 2025, 9:30 AM EDT - 3 months ago

Quanterix Announces Cooperation Agreement with Kent Lake Capital

Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC

Jul 28, 2025, 7:00 AM EDT - 3 months ago

Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jul 11, 2025, 5:00 PM EDT - 3 months ago

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum

Jul 8, 2025, 9:07 AM EDT - 3 months ago

Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum

Quanterix Expands Reach with IVD and Large Reference Labs

Jun 23, 2025, 7:30 AM EDT - 4 months ago

Quanterix Expands Reach with IVD and Large Reference Labs

Kent Lake Condemns Quanterix's Failure to Schedule Its 2025 Annual Meeting as a Tactic to Silence Shareholders

Jun 11, 2025, 8:00 AM EDT - 4 months ago

Kent Lake Condemns Quanterix's Failure to Schedule Its 2025 Annual Meeting as a Tactic to Silence Shareholders

Quanterix to Present at Goldman Sachs Global Healthcare Conference

Jun 6, 2025, 9:41 AM EDT - 5 months ago

Quanterix to Present at Goldman Sachs Global Healthcare Conference

Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal

May 23, 2025, 2:21 PM EDT - 5 months ago

Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal

AKYA

Quanterix Corporation (QTRX) Q1 2025 Earnings Call Transcript

May 12, 2025, 11:19 PM EDT - 6 months ago

Quanterix Corporation (QTRX) Q1 2025 Earnings Call Transcript

Quanterix Releases Financial Results for the First Quarter of 2025

May 12, 2025, 4:01 PM EDT - 6 months ago

Quanterix Releases Financial Results for the First Quarter of 2025

AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

May 7, 2025, 3:46 PM EDT - 6 months ago

AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

AKYA

Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025

May 5, 2025, 7:00 AM EDT - 6 months ago

Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025

Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders

Apr 30, 2025, 8:00 AM EDT - 6 months ago

Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders

AKYA

Quanterix and Akoya Biosciences Announce Amended Merger Agreement

Apr 29, 2025, 7:00 AM EDT - 6 months ago

Quanterix and Akoya Biosciences Announce Amended Merger Agreement

AKYA

Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders

Apr 17, 2025, 8:30 AM EDT - 6 months ago

Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders

Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences

Apr 14, 2025, 8:00 AM EDT - 7 months ago

Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences

AKYA

Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya

Apr 7, 2025, 8:15 AM EDT - 7 months ago

Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya

AKYA

Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit

Apr 1, 2025, 1:00 AM EDT - 7 months ago

Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit

Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences

Mar 24, 2025, 8:00 AM EDT - 7 months ago

Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences

AKYA

Quanterix Corporation (QTRX) Q4 2024 Earnings Call Transcript

Mar 17, 2025, 7:19 PM EDT - 8 months ago

Quanterix Corporation (QTRX) Q4 2024 Earnings Call Transcript

Quanterix Releases Financial Results for the Fourth Quarter of 2024

Mar 17, 2025, 4:01 PM EDT - 8 months ago

Quanterix Releases Financial Results for the Fourth Quarter of 2024

Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call

Mar 17, 2025, 4:00 PM EDT - 8 months ago

Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call

AKYA

Quanterix To Report Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

Mar 13, 2025, 1:00 PM EDT - 8 months ago

Quanterix To Report Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix's Proposed Merger with Akoya Biosciences

Mar 11, 2025, 8:00 AM EDT - 8 months ago

Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix's Proposed Merger with Akoya Biosciences

AKYA

Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board

Mar 3, 2025, 8:00 AM EST - 8 months ago

Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board

Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition

Mar 3, 2025, 6:00 AM EST - 8 months ago

Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition

The Schall Law Firm Invites Shareholders With Losses In Quanterix Corporation To Join A Securities Fraud Investigation

Mar 2, 2025, 11:00 AM EST - 8 months ago

The Schall Law Firm Invites Shareholders With Losses In Quanterix Corporation To Join A Securities Fraud Investigation

Neurogen Biomarking Announces Global Agreement with Quanterix for Use of Blood Biomarker Assay in its Patient-Initiated Blood Test to Support Early Detection of Dementia and Mild Cognitive Impairment Due to Alzheimer's Disease

Feb 19, 2025, 8:30 AM EST - 8 months ago

Neurogen Biomarking Announces Global Agreement with Quanterix for Use of Blood Biomarker Assay in its Patient-Initiated Blood Test to Support Early Detection of Dementia and Mild Cognitive Impairment Due to Alzheimer's Disease

Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company's Proposed Merger with Akoya Biosciences

Feb 18, 2025, 3:40 PM EST - 8 months ago

Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company's Proposed Merger with Akoya Biosciences

AKYA

Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Feb 14, 2025, 5:48 PM EST - 9 months ago

Quanterix Corporation Announcement: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Quanterix Investor News: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Feb 5, 2025, 3:43 PM EST - 9 months ago

Quanterix Investor News: If You Have Suffered Losses in Quanterix Corporation (NASDAQ: QTRX), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into Quanterix Corporation For Securities Fraud

Feb 1, 2025, 11:00 AM EST - 9 months ago

The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into Quanterix Corporation For Securities Fraud

Bragar Eagel & Squire, P.C. Is Investigating Quanterix and TransMedics and Encourages Investors to Contact the Firm

Jan 28, 2025, 9:00 PM EST - 9 months ago

Bragar Eagel & Squire, P.C. Is Investigating Quanterix and TransMedics and Encourages Investors to Contact the Firm

TMDX

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Quanterix Corporation For Securities Fraud

Jan 28, 2025, 11:00 AM EST - 9 months ago

The Schall Law Firm Invites Shareholders With Losses To Join An Inquiry Into Quanterix Corporation For Securities Fraud

Quanterix Provides Update on Financial Performance

Jan 14, 2025, 7:00 AM EST - 10 months ago

Quanterix Provides Update on Financial Performance

Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers

Jan 10, 2025, 7:00 AM EST - 10 months ago

Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers

AKYA

David R. Walt Receives National Medal of Technology and Innovation

Jan 6, 2025, 9:30 AM EST - 10 months ago

David R. Walt Receives National Medal of Technology and Innovation

Quanterix to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 2, 2025, 4:26 PM EST - 10 months ago

Quanterix to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Farorm
Farorm Oct. 16 at 5:26 PM
$QTRX it’s time 🚀
0 · Reply
Will2ride1
Will2ride1 Oct. 9 at 6:52 PM
$QTRX when the CFO buys...you buy
0 · Reply
smartmoney43
smartmoney43 Oct. 8 at 10:04 PM
$QTRX looks interesting
0 · Reply
TAE63
TAE63 Oct. 5 at 6:23 PM
A steady mover to launch the week points to $QTRX .
0 · Reply
Will2ride1
Will2ride1 Oct. 3 at 2:04 PM
$QTRX 👁📈
0 · Reply
Will2ride1
Will2ride1 Oct. 2 at 8:03 PM
$QTRX ✅️
0 · Reply
sogenerous
sogenerous Oct. 1 at 2:34 PM
$QTRX sold half here +8%
1 · Reply
sogenerous
sogenerous Oct. 1 at 1:53 PM
$QTRX im 2 good to you guys
1 · Reply
ahab
ahab Sep. 29 at 3:03 PM
$QTRX Joining So generous on this one, nice setup PT$7
0 · Reply
sogenerous
sogenerous Sep. 29 at 2:13 PM
$QTRX I have rebought a starter in this name after a long time. Trading at negative valuation to cash and huge insider buys. hopefully I will get the bottom this time on this name like the last 2 times.
1 · Reply
Ivolotti
Ivolotti Sep. 17 at 3:27 PM
$QTRX is your market also closed for quanterix currently???
0 · Reply
Will2ride1
Will2ride1 Sep. 17 at 2:35 PM
$QTRX insider buying CFO
0 · Reply
Will2ride1
Will2ride1 Sep. 17 at 12:24 AM
$QTRX still very much at discount price....bully!
0 · Reply
Will2ride1
Will2ride1 Sep. 13 at 12:04 AM
$QTRX dip & rip
0 · Reply
Swick02
Swick02 Sep. 12 at 5:09 PM
$QTRX this has been an absolute disaster of an investment over the years. Thankfully made bank on the run over $80-$90 in the COVID years. But it’s been a painful ride down. Looks like it might be finally breaking out above its long downtrend line. If they can actually stabilize the revenue and get to cash flow breakeven, I think it can be worth 3x-4x revenue, or $15. I’ve built up an overweight position again here below $5. Reimbursement price for their LucentAD test was announced this week at $897, I believe above market expectations and well above feared levels. There is also a prospect to seeing their reagent kits used in a significantly larger base of non Quanterix equipment. Reagents are where the margins are. Perhaps this is finally the bottom???
0 · Reply
Will2ride1
Will2ride1 Sep. 11 at 6:52 PM
$QTRX 👁📈
0 · Reply
_www_larval_com_
_www_larval_com_ Sep. 10 at 1:37 PM
$CIFR 9%[12%] $HYPD 7%[12%] $NAKA -6%[-33%] $LUMN 6%[8%] $QTRX 5%[8%] most notable movement within the first minutes of trading.
0 · Reply
KostasBars
KostasBars Sep. 10 at 10:39 AM
$QTRX Quanterix is the manufacturer of the p-tau217 blood test being trialled in the UK for Alzheimer’s diagnosis https://news.sky.com/story/uk-patients-to-trial-blood-test-that-could-revolutionise-alzheimers-diagnosis-13428001
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 8 at 8:33 PM
$QTRX Brilliant piece that captures QTRX's situation perfectly. So if you want to update your understanding of QTRX or get to know QTRX better, this is essential reading. https://beyondspx.com/quote/QTRX/analysis/quanterix-ultra-sensitivity-strategic-expansion-and-the-path-to-profitability-qtrx
0 · Reply
lowfloatscambuster
lowfloatscambuster Sep. 5 at 12:10 PM
$QTRX make sure you WITHOLD Massoud’s board vote on your proxy and vote AGAINST mgmt comp. These fucktard clowns need to go.
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Aug. 22 at 10:20 AM
WATCHLIST AUG 22 2025 $NTRA Natera Launches Proprietary AI Foundation Models Built On 250,000+ Tumor Exomes And 1M+ Plasma Timepoints To Advance Oncology Diagnostics And Therapeutics $FFAI Faraday X Announces FX Super One Multi Purpose Vehicle Successfully Completes First Federal Motor Vehicle Safety Standards Development Tests $QTRX Quanterix Accelerator Laboratory Receives New York State Clinical Laboratory Permit; Permit Approval Enables Expanded Research Capabilities And Underscores Commitment To Accuracy, Reliability, And Scientific Excellence $ROST Ross Stores shares are trading higher after the company reported better-than-expected Q2 EPS results and issued Q4 GAAP EPS guidance above estimates. $AMBO Ambow Education Launches HybriU Events To Power Immersive, AI-Driven Interactive Live Experiences With Global Multi-Language Accessibility
0 · Reply
McKenna14
McKenna14 Aug. 22 at 12:57 AM
$QTRX hello , is there anybody ?
1 · Reply